hVIVO Results Centre | Annual & Interim Reports
hVIVO Results Centre | Annual & Interim Reports
4 weeks ago
hvivo.com
hVIVO secures Traws influenza challenge study
4:50
hVIVO secures Traws influenza challenge study
1 month ago
YahooProactive
hVIVO: beating the odds in 2025 - and why 2026 looks better still
8:11
hVIVO: beating the odds in 2025 - and why 2026 looks better still
1 month ago
YahooProactive
hVIVO, Connecting Excellence, ACG Metals, Kodal Minerals, Ariana Resources, Sunda Energy
1:38
hVIVO, Connecting Excellence, ACG Metals, Kodal Minerals, Ariana Re…
1 month ago
YahooProactive
hVIVO plc signe un accord d'essai clinique avec Traws Pharma
hVIVO plc signe un accord d'essai clinique avec Traws Pharma
1 month ago
zonebourse.com
hVIVO, Rift Helium, Galliford Try, Valereum, accesso, Solvonis Therapeutics - Small Cap Snapshot
1:59
hVIVO, Rift Helium, Galliford Try, Valereum, accesso, Solvonis Ther…
3 weeks ago
YahooProactive
hVIVO lands third challenge trial contract as market picks up sharply
4:34
hVIVO lands third challenge trial contract as market picks up sharply
1 week ago
YahooProactive
hVIVO full-year results: Growth strategy and outlook - ICYMI
3 weeks ago
YahooProactive
hVIVO Lands Influenza Trial Deal
3 weeks ago
voxmarkets.com
hVIVO expands human challenge study portfolio - ICYMI
6 months ago
proactiveinvestors.com
hVIVO Lands Landmark Phase III Trial
2 weeks ago
voxmarkets.com
hVIVO beats 2025 EBITDA forecasts, eyes growth in 2026
3 months ago
proactiveinvestors.com
hVIVO sees uptick in human challenge trial demand - ICYMI
2 days ago
proactiveinvestors.com
hVIVO CEO on milestone Phase III whooping cough trial for ILiAD
3 weeks ago
proactiveinvestors.com
hVIVO lands third challenge trial contract as market picks up sharply
1 week ago
proactiveinvestors.com
hVIVO, Rift Helium, Galliford Try, Valereum, accesso, Solvonis Ther…
3 weeks ago
proactiveinvestors.com
hVIVO shares rise 7% as Cavendish hails "landmark" whooping coug…
3 weeks ago
proactiveinvestors.com
hVIVO, Bango, Light Science Technologies, Active Energy, Seei…
6 days ago
proactiveinvestors.com
hVIVO CEO on milestone Phase III whooping cough trial for ILiAD
2 weeks ago
centralcharts.com
hVIVO: beating the odds in 2025 - and why 2026 looks better still
1 month ago
proactiveinvestors.com.au
HVIVO eyes double-digit revenue rise, announces new acquisition
Jan 29, 2025
marketscreener.com
HVIVO PLC Announces Significant HCT Contract Cancellation And Po…
11 months ago
marketscreener.com
3:34
Solvonis Therapeutics, hVIVO, OptiBiotix Health, Genflow Bioscie…
3 months ago
YahooProactive
hVIVO opens new state-of-the art trial centre in Canary Wharf hub
Aug 28, 2023
proactiveinvestors.com
8:21
hVIVO beats 2025 EBITDA forecasts, eyes growth in 2026
3 months ago
YahooProactive
hVIVO upgraded after human challenge trial contract win
Jan 27, 2025
proactiveinvestors.co.uk
hVIVO eyes 2026 growth after strong H1 update
9 months ago
proactiveinvestors.co.uk
hVIVO secures £11.5m RSV contract and confirms guidance
Dec 9, 2024
proactiveinvestors.co.uk
hVIVO CEO on record 2024 revenue and strategic CRS acquisition
Jan 28, 2025
proactiveinvestors.co.uk
hVIVO eyes 2026 growth after H1 update - ICYMI
9 months ago
proactiveinvestors.co.uk
See more videos
Static thumbnail place holder